Dr. Maher Banjari is a renowned internal medicine consultant at King's College Hospital London in Jeddah, recognized for his exceptional expertise and compassionate approach to patient care. With over 10 years of experience in internal medicine, Dr. Banjari specializes in chronic diseases such as hypertension, diabetes, and lipid disorders, with a particular interest in systemic lupus erythematosus and psoriatic arthritis.
He obtained his medical degree from King Abdulaziz University in Jeddah, followed by specialized training in internal medicine at esteemed institutions in France. He then served as a clinical fellow in rheumatology at the University of Toronto. In addition to his clinical work, Dr. Banjari is deeply engaged in research and education. In 2022, he received an award for the best abstract from the Canadian Rheumatology Association for his research on SLE and COVID. Passionate about teaching and mentoring, he aims to enhance the clinical skills and knowledge of other healthcare professionals.
Areas of expertise.
Education and training.
- 01Clinical fellowship in Systemic Lupus Erythematosus and Psoriatic Arthritis, University of Toronto (2020-2022)
- 02Diploma in therapeutic strategies in infectious diseases, Paris, 2016
- 03Internal Medicine Residency – France (2014-2019)
- 04Medical school – King Abdulaziz University, Jeddah (2006-2013)
Boards and fellowships.
- 01Internal Medicine Consultant (SCFHS )
- 02Registered member of the College of Physicians and Surgeons of Ontario (CPSO), 2021
- 03Diploma in therapeutic strategies in infectious disease, Paris – 2017DES Internal Medicine, France – 2019
- 04MBBS, King Abdulaziz University – 2013
Selected publications.
- 01Improving measures of disease activity in systemic lupus erythematosus, 2023
- 02Toxoplasmosis in patients with an autoimmune disease and immunosuppressive agents: A multicenter study, 2022
- 03Infective endocarditis due to Neisseria elongata, A case report and literature review, 2021
- 04Polyarthritis due to Ureaplasma urealyticum favored by hypogammaglobulinemia, 2017